JBHT
56
3
AIZ
56
7
ZTS
34
-2
FCX
43
3
NWS
62
2
UPS
60
4
TGT
53
-3
MAS
52
9
MMC
44
5
AXP
67
4
CAT
57
6
EQIX
57
4
HAL
46
2
NAVI
30
6
AMP
50
4
PNC
53
5
NI
63
3
JCI
45
3
MDLZ
22
6
GOOG
63
2
JBHT
56
3
AIZ
56
7
ZTS
34
-2
FCX
43
3
NWS
62
2
UPS
60
4
TGT
53
-3
MAS
52
9
MMC
44
5
AXP
67
4
CAT
57
6
EQIX
57
4
HAL
46
2
NAVI
30
6
AMP
50
4
PNC
53
5
NI
63
3
JCI
45
3
MDLZ
22
6
GOOG
63
2
Financhill
Back

Cassava Sciences Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
28

SAVA
Cassava Sciences

Last Price:
$2.62
Seasonality Move:
20.94%
Buy
53

SRPT
Sarepta Therapeutics

Last Price:
$118.76
Seasonality Move:
6.9%
Sell
28
Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy, Sell or Hold?

  • The current Cassava Sciences [SAVA] share price is $2.61. The Score for SAVA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • SAVA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $118.83. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SAVA Stock Price Chart

What is Cassava Sciences's stock price today?

  • The Cassava Sciences share price today is $2.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $118.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

SAVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.84 Sell
Relative Strength Index (14 RSI): 28.35 Sell
Chaikin Money Flow: -1179246 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.44 - 2.92) Sell
Bollinger Bands (100): (7.78 - 31.42) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 42.61 Sell
Chaikin Money Flow: -1051033 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.51 - 126.69) Sell
Bollinger Bands (100): (117.54 - 132.72) Sell

SAVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.82 Sell
20-day SMA: 2.61 Sell
50-day SMA: 10.97 Sell
200-day SMA: 19.8 Sell
8-day EMA: 2.74 Sell
20-day EMA: 3.63 Sell
50-day EMA: 9.22 Sell
200-day EMA: 18.23 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.89 Sell
20-day SMA: 122.81 Sell
50-day SMA: 121.71 Sell
200-day SMA: 129.55 Sell
8-day EMA: 122.35 Sell
20-day EMA: 122.96 Sell
50-day EMA: 123.39 Sell
200-day EMA: 125.6 Sell

Cassava Sciences Earnings Growth & SAVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.88 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.80 per share, and an increase next year of $4.80 per share.

Cassava Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):